Form 4: LifeStance Health Exec's RSU Tax Withholding

Sentiment:

Insider Transaction Report


LifeStance Health Group, Inc. Executive Vice President Lisa K. Miller reported the withholding of 10,623 shares of common stock to cover tax obligations related to vested Restricted Stock Units.

Summary

  • Lisa K. Miller, Executive Vice President, Practice Operations at LifeStance Health Group, Inc. (LFST), reported a transaction on November 10, 2025.
  • The transaction involved the disposition of 10,623 shares of Common Stock at a price of $6.43 per share.
  • These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of Restricted Stock Units (RSUs) that vested on the same date.
  • This action represents a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and does not constitute an open-market sale.
  • Following this transaction, Lisa K. Miller beneficially owns 318,532 shares of Common Stock directly.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing reports a routine administrative transaction involving the withholding of shares for tax purposes upon RSU vesting, which is a neutral event for the company's operational or financial performance.

Positives

  • The transaction is a routine administrative action related to executive compensation, indicating the vesting of previously granted Restricted Stock Units (RSUs).

Negatives

  • The transaction is a routine administrative action related to executive compensation and does not indicate any negative operational or financial performance.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction related to executive compensation, which is a common occurrence across all industries for publicly traded companies with equity compensation plans. It does not provide specific insights into broader industry trends or competitive landscape.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compliance DisclosureThe transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan designed to comply with insider trading regulations.11/10/2025Enhances transparency and demonstrates adherence to insider trading policies, mitigating concerns about opportunistic trading.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine tax withholding and not a discretionary sale. It reflects the vesting of previously granted compensation.

Key Dates

DateDescription
11/10/2025Date of earliest transaction, when Restricted Stock Units (RSUs) vested and shares were withheld for tax obligations.
11/13/2025Signature date of the reporting person's attorney-in-fact on the Form 4 filing.

Recommendation

hold

This Form 4 reports a routine administrative transaction where shares were withheld to cover tax obligations upon the vesting of Restricted Stock Units (RSUs). This is a standard practice for executive compensation and does not reflect a discretionary sale or provide new information regarding the company's operational performance or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

LifeStance Health Group, LFST, Form 4, Insider Transaction, RSU, Restricted Stock Units, Tax Withholding, Executive Compensation, Lisa K. Miller, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.